BlueCrest Capital Management’s Axogen AXGN Stock Holding History

BlueCrest Capital Management’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,105	Closed	-$299K	–	873
2018 Q3	$299K	Buy	+8,105	New	+$354K	0.01%	1043
2016 Q2	–	Sell	-14,390	Closed	-$77K	–	850
2016 Q1	$77K	Buy	+14,390	New	+$73.1K	﹤0.01%	729

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlueCrest Capital Management's AXGN Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Axogen (AXGN) in Q4 2018, closing a stake of 8,105 shares — an estimated $299K sold.

BlueCrest Capital Management first reported a position in AXGN in Q1 2016 and held it in 2 quarters. The position peaked at $299K in Q3 2018. 146 funds tracked by Wall St. Rank hold AXGN as of Q4 2018.

BlueCrest Capital Management reported no remaining Axogen position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 8,105 Axogen shares in Q4 2018, an estimated $299K.
BlueCrest Capital Management first reported a position in Axogen in Q1 2016 and held it in 2 quarters.
BlueCrest Capital Management's Axogen position peaked at $299K in Q3 2018.
146 funds tracked by Wall St. Rank held Axogen as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.